T1	Pharmacological_substance 0 9	Phenytoin
N1000 	Reference T1 MeSH:D010672	Phenytoin
T2	Pharmacological_substance 10 20	isradipine
N1001 	Reference T2 MeSH:D017275	isradipine
T3	Disorder 48 67	neurologic toxicity
N1 	Reference T3 UMLS:C0600688	neurologic toxicity
T4	Pharmacological_substance 94 103	phenytoin
N1002 	Reference T4 MeSH:D010672	phenytoin
T5	Disorder 118 143	acute neurologic symptoms
N2 	Reference T5 UMLS:C1457887	acute neurologic symptoms
T6	Pharmacological_substance 150 160	isradipine
N1003 	Reference T6 MeSH:D017275	isradipine
T7	Disorder 289 307	propionic acidemia
N3 	Reference T7 UMLS:C0268579	propionic acidemia
T8	Disorder 312 320	seizures
N4 	Reference T8 UMLS:C0036572	seizures
T9	Pharmacological_substance 334 343	phenytoin
N1004 	Reference T9 MeSH:D010672	phenytoin
T10	Pharmacological_substance 348 361	carbamazepine
N1005 	Reference T10 MeSH:D002220	carbamazepine
T11	Pharmacological_substance 378 388	isradipine
N1006 	Reference T11 MeSH:D017275	isradipine
T12	Disorder 403 415	hypertension
N5 	Reference T12 UMLS:C0020538	hypertension
T13	Disorder 464 472	lethargy
N6 	Reference T13 UMLS:C0023380	lethargy
T14	Disorder 474 480	ataxia
N7 	Reference T14 UMLS:C0004134	ataxia
T15	Disorder 482 492	dysarthria
N8 	Reference T15 UMLS:C0013362	dysarthria
T16	Pharmacological_substance 526 536	isradipine
N1007 	Reference T16 MeSH:D017275	isradipine
T17	Pharmacological_substance 551 560	Phenytoin
N1008 	Reference T17 MeSH:D010672	Phenytoin
T18	Pharmacological_substance 648 657	phenytoin
N1009 	Reference T18 MeSH:D010672	phenytoin
T19	Pharmacological_substance 685 695	isradipine
N1010 	Reference T19 MeSH:D017275	isradipine
T20	Pharmacological_substance 712 722	Isradipine
N1011 	Reference T20 MeSH:D017275	Isradipine
T22	Pharmacological_substance 803 812	phenytoin
N1012 	Reference T22 MeSH:D010672	phenytoin
T23	Pharmacological_substance 842 851	phenytoin
N1013 	Reference T23 MeSH:D010672	phenytoin
T24	Disorder 968 987	neurologic symptoms
N9 	Reference T24 UMLS:C0235031	neurologic symptoms
T25	Pharmacological_substance 1014 1023	phenytoin
N1014 	Reference T25 MeSH:D010672	phenytoin
T26	Pharmacological_substance 1105 1114	phenytoin
N1015 	Reference T26 MeSH:D010672	phenytoin
T27	Pharmacological_substance 1123 1146	calcium-channel blocker
N1016 	Reference T27 MeSH:D002121	calcium-channel blocker
T28	Pharmacological_substance 1153 1162	phenytoin
N1017 	Reference T28 MeSH:D010672	phenytoin
T29	Pharmacological_substance 1167 1177	isradipine
N1018 	Reference T29 MeSH:D017275	isradipine
T31	Pharmacological_substance 1278 1288	isradipine
N1019 	Reference T31 MeSH:D017275	isradipine
T32	Pharmacological_substance 1348 1372	calcium-channel blockers
N1020 	Reference T32 MeSH:D002121	calcium-channel blockers
T33	Pharmacological_substance 1439 1448	phenytoin
N1021 	Reference T33 MeSH:D010672	phenytoin
T34	Pharmacological_substance 1513 1522	phenytoin
N1022 	Reference T34 MeSH:D010672	phenytoin
T35	Pharmacological_substance 1527 1537	isradipine
N1023 	Reference T35 MeSH:D017275	isradipine
T36	Disorder 1572 1580	lethargy
N10 	Reference T36 UMLS:C0023380	lethargy
T37	Disorder 1582 1592	dysarthria
N11 	Reference T37 UMLS:C0013362	dysarthria
T38	Disorder 1594 1600	ataxia
N12 	Reference T38 UMLS:C0004134	ataxia
T39	Pharmacological_substance 1657 1666	phenytoin
N1024 	Reference T39 MeSH:D010672	phenytoin
T40	Pharmacological_substance 1671 1695	calcium-channel blockers
N1025 	Reference T40 MeSH:D002121	calcium-channel blockers
T43	Subject 79 90	a young man
T47	Speculation_cue 217 225	possible
T48	Subject 259 282	A 21-year-old white man
T55	Disorder 498 506	weakness
N13 	Reference T55 UMLS:C3714552	weakness
T59	Pharmacological_substance 1237 1244	calcium
N1026 	Reference T59 MeSH:D002118	calcium
T62	Speculation_cue 1062 1068	likely
T66	Subject 1324 1330	humans
T67	Subject 1335 1342	animals
T73	Disorder 1606 1614	weakness
N14 	Reference T73 UMLS:C3714552	weakness
T74	Speculation_cue 1543 1551	probably
T78	Speculation_cue 1716 1723	caution
T76	Combination 1642 1653	combination
T21	Combination 344 347	and
